+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


RXi Pharmaceuticals Corp (RXII) - Financial and Strategic SWOT Analysis Review

  • ID: 4278610
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


RXi Pharmaceuticals Corp (RXi) is a biotechnology company that discovers, develops and commercializes therapies based on RNAi platform. The company’s products comprise RXI-109 and samcyprone gel. Its RXI-109 is an RNAi compound, which is used to reduce the expression of critical regulator of several biological pathways in fibrosis such as scar formation in the skin. RXi offers products for the treatment of anti scarring, macular degeneration, retinoblastoma, and liver diseases. The company uses RNAi and sd-rxRNA technologies for the development of products. It partners with academia, biotech, and large multi-national organizations for the development of new therapeutics. RXi is headquartered in Marlborough, Massachusetts, the US.

RXi Pharmaceuticals Corp Key Recent Developments

Feb 05, 2018: RXi Pharmaceuticals to Present at the BIO CEO and Investor Conference
Jan 17, 2018: RXi Pharmaceuticals to Present at Immuno-Oncology Frontiers World Conference
Jan 16, 2018: RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
Dec 29, 2017: RXi Pharmaceuticals to Present at the 10th Annual Biotech Showcase Conference
Nov 29, 2017: RXi Pharmaceuticals Announces Positive Results with RXI-231 in Consumer Testing Program

This comprehensive SWOT profile of RXi Pharmaceuticals Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of RXi Pharmaceuticals Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • RXi Pharmaceuticals Corp - Key Information
  • RXi Pharmaceuticals Corp - Overview
  • RXi Pharmaceuticals Corp - Key Employees
  • RXi Pharmaceuticals Corp - Key Employee Biographies
  • RXi Pharmaceuticals Corp - Key Operational Heads
  • RXi Pharmaceuticals Corp - Major Products and Services
  • RXi Pharmaceuticals Corp - History
  • RXi Pharmaceuticals Corp - Company Statement
  • RXi Pharmaceuticals Corp - Locations And Subsidiaries
  • RXi Pharmaceuticals Corp - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • RXi Pharmaceuticals Corp - Business Description
  • RXi Pharmaceuticals Corp - Corporate Strategy
  • RXi Pharmaceuticals Corp - SWOT Analysis
  • SWOT Analysis - Overview
  • RXi Pharmaceuticals Corp - Strengths
  • RXi Pharmaceuticals Corp - Weaknesses
  • RXi Pharmaceuticals Corp - Opportunities
  • RXi Pharmaceuticals Corp - Threats
  • RXi Pharmaceuticals Corp - Key Competitors
Section 3 - Company Financial Performance Charts
  • RXi Pharmaceuticals Corp - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • RXi Pharmaceuticals Corp, Key Information
  • RXi Pharmaceuticals Corp, Key Ratios
  • RXi Pharmaceuticals Corp, Share Data
  • RXi Pharmaceuticals Corp, Major Products and Services
  • RXi Pharmaceuticals Corp, History
  • RXi Pharmaceuticals Corp, Key Employees
  • RXi Pharmaceuticals Corp, Key Employee Biographies
  • RXi Pharmaceuticals Corp, Key Operational Heads
  • RXi Pharmaceuticals Corp, Other Locations
  • RXi Pharmaceuticals Corp, Subsidiaries
  • RXi Pharmaceuticals Corp, Key Manufacturing facilities
  • RXi Pharmaceuticals Corp, Key Competitors
  • RXi Pharmaceuticals Corp, SWOT Analysis
  • RXi Pharmaceuticals Corp, Ratios based on current share price
  • RXi Pharmaceuticals Corp, Annual Ratios
  • RXi Pharmaceuticals Corp, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • RXi Pharmaceuticals Corp, Performance Chart
  • RXi Pharmaceuticals Corp, Ratio Charts
Note: Product cover images may vary from those shown